Arvinas Androgen Receptor, Inc.
1 clinical trials · Sponsor
◉ Watch Arvinas Androgen Receptor, Inc.
| Record | Firm | Date |
|---|---|---|
| Trial of ARV-110 and Abiraterone in Participants With Metastatic Prostate Cancer (NCT05177042) | Arvinas Androgen Receptor, Inc. | 2022-05-13 |
Track Arvinas Androgen Receptor, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.